Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 134


Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae.

Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC.

Infect Immun. 2007 Jan;75(1):350-7. Epub 2006 Nov 6.


Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.

Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, Zhao Q, Liu B, Wang D, Zhang X, Shan Y, Yin Y.

Vaccine. 2007 Jun 28;25(27):4996-5005. Epub 2007 May 11.


Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.

Ogunniyi AD, Woodrow MC, Poolman JT, Paton JC.

Infect Immun. 2001 Oct;69(10):5997-6003.


PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.

Xin W, Li Y, Mo H, Roland KL, Curtiss R 3rd.

Infect Immun. 2009 Oct;77(10):4518-28. doi: 10.1128/IAI.00486-09. Epub 2009 Aug 17.


Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.

Lu J, Sun T, Wang D, Dong Y, Xu M, Hou H, Kong FT, Liang C, Gu T, Chen P, Sun S, Lv X, Jiang C, Kong W, Wu Y.

Immunol Invest. 2015;44(5):482-96. doi: 10.3109/08820139.2015.1037956.


Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.

Brown JS, Ogunniyi AD, Woodrow MC, Holden DW, Paton JC.

Infect Immun. 2001 Nov;69(11):6702-6. Erratum in: Infect Immun. 2004 Nov;72(11):6755.


Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.

Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.

Microb Pathog. 2009 Sep;47(3):151-6. doi: 10.1016/j.micpath.2009.05.004. Epub 2009 May 23.


Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae Infections in Mice.

Wu K, Zhang X, Shi J, Li N, Li D, Luo M, Cao J, Yin N, Wang H, Xu W, He Y, Yin Y.

Infect Immun. 2010 Mar;78(3):1276-83. doi: 10.1128/IAI.00473-09. Epub 2009 Dec 28.


Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.

Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH.

Vaccine. 2011 Aug 5;29(34):5731-9. doi: 10.1016/j.vaccine.2011.05.095. Epub 2011 Jun 13.


Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.

Lin H, Peng Y, Lin Z, Zhang S, Guo Y.

Microb Pathog. 2015 Jun-Jul;83-84:35-40. doi: 10.1016/j.micpath.2015.04.006. Epub 2015 May 7.


Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.

Salcedo-Rivillas C, Debrie AS, Miyaji EN, Ferreira JM Jr, Raw I, Locht C, Ho PL, Mielcarek N, Oliveira ML.

Clin Vaccine Immunol. 2014 Jul;21(7):972-81. doi: 10.1128/CVI.00134-14. Epub 2014 May 7.


Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.

Moreno AT, Oliveira ML, Ferreira DM, Ho PL, Darrieux M, Leite LC, Ferreira JM Jr, Pimenta FC, Andrade AL, Miyaji EN.

Clin Vaccine Immunol. 2010 Mar;17(3):439-46. doi: 10.1128/CVI.00430-09. Epub 2010 Jan 20.


Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.

Oliveira ML, Miyaji EN, Ferreira DM, Moreno AT, Ferreira PC, Lima FA, Santos FL, Sakauchi MA, Takata CS, Higashi HG, Raw I, Kubrusly FS, Ho PL.

PLoS One. 2010 May 27;5(5):e10863. doi: 10.1371/journal.pone.0010863.


Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.

Kong IG, Sato A, Yuki Y, Nochi T, Takahashi H, Sawada S, Mejima M, Kurokawa S, Okada K, Sato S, Briles DE, Kunisawa J, Inoue Y, Yamamoto M, Akiyoshi K, Kiyono H.

Infect Immun. 2013 May;81(5):1625-34. doi: 10.1128/IAI.00240-13. Epub 2013 Mar 4.


Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.

Olafsdottir TA, Lingnau K, Nagy E, Jonsdottir I.

Infect Immun. 2012 Jan;80(1):461-8. doi: 10.1128/IAI.05801-11. Epub 2011 Oct 24.


The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.

Daniels CC, Coan P, King J, Hale J, Benton KA, Briles DE, Hollingshead SK.

Infect Immun. 2010 May;78(5):2163-72. doi: 10.1128/IAI.01199-09. Epub 2010 Mar 1.


Protection against pneumococcal infection elicited by immunization with multiple pneumococcal heat shock proteins.

Cao J, Zhang X, Gong Y, Zhang Y, Cui Y, Lai X, Yin Y, Li M, Li D, Zhang L.

Vaccine. 2013 Aug 2;31(35):3564-71. doi: 10.1016/j.vaccine.2013.05.061. Epub 2013 May 29.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk